Saturday, Nov 21, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Hyderabad | Teneligliptin Alert Cdsco Adds Bullous Pemphigoid To Drug Safety Warning

Teneligliptin alert: CDSCO adds bullous pemphigoid to drug safety warning

CDSCO has alerted patients taking teneligliptin about bullous pemphigoid, a rare autoimmune skin condition, and directed drug companies to update safety information. Diabetologists advised patients not to stop medication without consulting doctors and to report unusual blistering rashes promptly

By Telangana Today
Published Date - 4 October 2026, 03:18 PM
Teneligliptin alert: CDSCO adds bullous pemphigoid to drug safety warning
Representational Image
whatsapp facebook twitter telegram

Hyderabad: India’s top drug safety regulator has issued an alert for patients taking the widely prescribed anti-diabetic drug teneligliptin, sold under popular brand names such as Tenglyn, Teniva and Tenepla, to include the rare skin condition bullous pemphigoid as an adverse drug reaction.

As part of the alert, the Central Drugs Standard Control Organisation (CDSCO) has directed drug companies to update the package inserts and promotional literature for the drug, which is used to manage Type 2 diabetes.


The alert follows reviews by the National Coordination Centre for the Pharmacovigilance Programme of India and the Subject Expert Committee, which tracked real-world adverse drug reaction reports using national databases such as VigiFlow.

Bullous pemphigoid is a rare autoimmune skin condition marked by large, painful and intensely itchy, fluid-filled blisters that require medical attention. Diabetologists have also urged patients to remain vigilant about unexplained rashes, hives or skin irritation when starting or continuing long-term medication.

Pharmacovigilance systems rely heavily on patients and doctors reporting unusual health changes, making public awareness an important first line of defence in ensuring drug safety.

A few weeks ago, CDSCO issued a similar warning for patients taking commonly used painkillers and anti-inflammatory drugs such as aceclofenac and ibuprofen after reviews flagged the risk of a recurrent skin condition called fixed drug eruption.

Similar to the earlier warnings, the new advisory on teneligliptin aims to give doctors and patients greater awareness of rare side effects.

Diabetologists, however, stressed that patients should never stop or alter their diabetes medication without consulting their doctor, as sudden changes could destabilise blood sugar levels. If a family member or acquaintance develops unusual blistering skin rashes while taking a teneligliptin-based medication, they should immediately consult a doctor about any necessary changes to their prescription.

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • CDSCO teneligliptin alert
  • teneligliptin bullous pemphigoid
  • teneligliptin safety warning
  • teneligliptin side effects

Related News

    Latest News

    • Pankaj Advani enters World Snooker semi-finals

      55 minutes ago
    • Loknath Naik’s 104 powers Hyderabad to police T20 title

      1 hour ago
    • Lakshya Rajesh, Shaina Manimuthu set up girls’ singles title clash

      1 hour ago
    • Karandeep Kochhar ends Gaganjeet Bhullar’s winning streak

      1 hour ago
    • FCI Headquarters win third successive Inter-Zonal Hockey Championship

      1 hour ago
    • Mamata Medical College beat G9 Academy in Hyderabad basketball league

      1 hour ago
    • BVP Rao urges IOC to monitor Indian Olympic Association elections

      1 hour ago
    • Telugu Black Hawks enter CAVA Volleyball Club Championship semi-finals

      1 hour ago

    company

    • Home
    • About Us
    • Contact Us
    • Privacy Policy

    business

    • Subscribe

    telangana today

    • Telangana
    • Hyderabad
    • Latest News
    • Entertainment
    • World
    • Andhra Pradesh
    • Science & Tech
    • Sport

    follow us

    • Telangana Today Telangana Today
    Telangana Today Telangana Today

    © Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

    Telangana Today App